Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Breast Cancer

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 51 articles: HTML format Text format

Single Articles

January 2012
1. RUGBJERG K , Friis S, Lassen CF, Ritz B, et al
   Malignant melanoma, breast cancer and other cancers in patients with parkinson disease.
   Int J Cancer. 2012 Jan 25. doi: 10.1002/ijc.27443.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
2. POSCHKE I , De Boniface J, Mao Y, Kiessling R, et al
   Tumor-induced changes in the phenotype of blood-derived and tumor-associated T cells of early-stage breast cancer patients.
   Int J Cancer. 2011 Dec 20. doi: 10.1002/ijc.27410.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
3. WHITE KK , Park SY, Kolonel LN, Henderson BE, et al
   Body size and breast cancer risk: The multiethnic cohort.
   Int J Cancer. 2011 Nov 28. doi: 10.1002/ijc.27373.
   PubMed     Text format     Related articles   
   
   
   
   October 2011
4. DEVARAJAN E , Song YH, Krishnappa S, Alt E, et al
   Epithelial-mesenchymal transition in breast cancer lines is mediated through PDGF-D released by tissue-resident stem cells.
   Int J Cancer. 2011 Oct 31. doi: 10.1002/ijc.26493.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. FACKENTHAL JD , Zhang J, Zhang B, Zheng Y, et al
   High prevalence of BRCA1 and BRCA2 mutations in unselected nigerian breast cancer patients.
   Int J Cancer. 2011 Oct 27. doi: 10.1002/ijc.27326.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
6. REEVES GK , Pirie K, Green J, Bull D, et al
   Comparison of the effects of genetic and environmental risk factors on IN SITU and invasive ductal breast cancer.
   Int J Cancer. 2011 Sep 27. doi: 10.1002/ijc.26460.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. SONG CZ , Wang QW, Song CC
   Hemorphin as a prognostic biomarker and potential drug for breast cancer?
   Int J Cancer. 2011 Sep 22. doi: 10.1002/ijc.26450.
   PubMed     Text format     Related articles   
   
   
   
   
8. MATHIESEN RR , Fjelldal R, Liestol K, Due EU, et al
   High resolution analyses of copy number changes in disseminated tumor cells of patients with breast cancer.
   Int J Cancer. 2011 Sep 20. doi: 10.1002/ijc.26444.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. SEIBOLD P , Hein R, Schmezer P, Hall P, et al
   Polymorphisms in oxidative stress-related genes and postmenopausal breast cancer risk.
   Int J Cancer. 2011;129:1467-76.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. ZIDAN J , Sikorsky N, Basher W, Sharabi A, et al
    Differences in pathological and clinical features of breast cancer in Arab as compared to Jewish women in Northern Israel.
    Int J Cancer. 2011 Sep 14. doi: 10.1002/ijc.26431.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
11. JEZEQUEL P , Campion L, Spyratos F, Loussouarn D, et al
    Validation of tumour-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumours: A multicentric 2004 national PHRC study.
    Int J Cancer. 2011 Aug 26. doi: 10.1002/ijc.26397.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. MAURICE A , Evans DG, Affen J, Greenhalgh R, et al
    Surveillance of women at increased risk of breast cancer using mammography and clinical breast examination: Further evidence of benefit.
    Int J Cancer. 2011 Aug 23. doi: 10.1002/ijc.26394.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. LIBREROS S , Garcia-Areas R, Shibata Y, Carrio R, et al
    Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: Decreased tumor metastasis in a breast cancer model.
    Int J Cancer. 2011 Aug 22. doi: 10.1002/ijc.26379.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. GIERACH GL , Freedman ND, Andaya A, Hollenbeck AR, et al
    Coffee intake and breast cancer risk in the NIH-AARP diet and health study cohort.
    Int J Cancer. 2011 Aug 16. doi: 10.1002/ijc.26372.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. LUBINSKI J , Huzarski T, Byrski T, Lynch HT, et al
    The risk of breast cancer in women with a BRCA1 mutation from north america and poland.
    Int J Cancer. 2011 Aug 10. doi: 10.1002/ijc.26369.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. DE BONIFACE J , Poschke I, Mao Y, Kiessling R, et al
    Tumor-dependent down-regulation of the zeta-chain in T-cells is detectable in early breast cancer and correlates with immune cell function.
    Int J Cancer. 2011 Aug 5. doi: 10.1002/ijc.26355.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. MEDEIROS PJ , Al-Khazraji BK, Novielli NM, Postovit LM, et al
    Neuropeptide Y stimulates proliferation and migration in the 4T1 breast cancer cell line.
    Int J Cancer. 2011 Aug 5. doi: 10.1002/ijc.26350.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. SOKOLENKO AP , Iyevleva AG, Preobrazhenskaya EV, Mitiushkina NV, et al
    High prevalence and breast cancer predisposing role of the BLMc.1642 C>T (Q548X) mutation in Russia.
    Int J Cancer. 2011 Aug 3. doi: 10.1002/ijc.26342.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
19. PAN B , Ren H, Ma Y, Liu D, et al
    HDL of patients with type 2 diabetes mellitus elevates the capability of promoting migration and invasion of breast cancer cells.
    Int J Cancer. 2011 Jul 29. doi: 10.1002/ijc.26341.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. TOMLINSON D , Knowles M, Speirs V
    Mechanisms of FGFR3 actions in endocrine resistant breast cancer.
    Int J Cancer. 2011 Jul 25. doi: 10.1002/ijc.26304.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. SUN C , Huo D, Nemesure B, Hennis A, et al
    Lack of association between common UGT2B nonsynonymous SNPs and breast cancer in populations of African ancestry.
    Int J Cancer. 2011 Jul 21. doi: 10.1002/ijc.26300.
    PubMed     Text format     Related articles   
    
    
    
    
22. FRERE-BELDA MA , Bats AS, Gillaizeau F, Poulet B, et al
    Diagnostic performance of one-step nucleic acid amplification for intraoperative sentinel node metastasis detection in breast cancer patients.
    Int J Cancer. 2011 Jul 21. doi: 10.1002/ijc.26291.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. HOFVIND S , Sakshaug S, Ursin G, Graff-Iversen S, et al
    Breast cancer incidence trends in Norway - explained by hormone therapy or mammographic screening?
    Int J Cancer. 2011 Jul 5. doi: 10.1002/ijc.26280.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
24. ARIMA Y , Hayashi N, Hayashi H, Sasaki M, et al
    Loss of p16 expression is associated with the stem cell characteristics of surface markers and therapeutic resistance in estrogen receptor-negative breast cancer.
    Int J Cancer. 2011 Jun 29. doi: 10.1002/ijc.26271.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. GATES MA , Xu M, Chen WY, Kraft P, et al
    ABO blood group and breast cancer incidence and survival.
    Int J Cancer. 2011 Jun 1. doi: 10.1002/ijc.26220.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
26. VERKOOIJEN HM , Hartman M, Usel M, Benhamou S, et al
    Breast cancer prognosis is inherited independently of patient, tumour, and treatment characteristics.
    Int J Cancer. 2011 May 31. doi: 10.1002/ijc.26206.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. CONROY SM , Woolcott CG, Koga KR, Byrne C, et al
    Mammographic density and risk of breast cancer by adiposity: An analysis of four case-control studies.
    Int J Cancer. 2011 May 31. doi: 10.1002/ijc.26205.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. GERMANO S , Kennedy S, Rani S, Gleeson G, et al
    MAGE-D4B is a novel marker of poor prognosis and potential therapeutic target involved in breast cancer tumorigenesis.
    Int J Cancer. 2011 May 26. doi: 10.1002/ijc.26200.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. PREET R , Mohapatra P, Mohanty S, Sahu SK, et al
    Quinacrine has anti-cancer activity in breast cancer cells through inhibition of topoisomerase activity.
    Int J Cancer. 2011 May 4. doi: 10.1002/ijc.26158.
    PubMed     Text format     Related articles   
    
    
    
    
30. ZAINEDDIN AK , Vrieling A, Buck K, Becker S, et al
    Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and HER2 receptor status.
    Int J Cancer. 2011 May 4. doi: 10.1002/ijc.26157.
    PubMed     Text format     Related articles   
    
    
    
    
31. YAMAUCHI C , Fujii S, Kimura T, Kuwata T, et al
    E-cadherin expression on human carcinoma cell affects trastuzumab-mediated antibody-dependent cellular cytotoxicity through killer cell lectin-like receptor G1 on natural killer cells.
    Int J Cancer. 2011;128:2125-37.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
32. ZHOU Z , Liu R, Chen C
    The WWP1 ubiquitin E3 ligase increases TRAIL resistance in breast cancer.
    Int J Cancer. 2011 Apr 7. doi: 10.1002/ijc.26122.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. ANDREOPOULOU E , Yang LY, Rangel KM, Reuben JM, et al
    Comparison of assay methods for detection of circulating tumor cells (CTCs) in metastatic breast cancer (MBC): AdnaGen AdnaTest BreastCancer Select/Detect versus Veridex CellSearch system.
    Int J Cancer. 2011 Apr 5. doi: 10.1002/ijc.26111.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
34. JACK RH , Davies EA, Moller H
    Breast cancer and age in black and white women in South East England.
    Int J Cancer. 2011 Mar 28. doi: 10.1002/ijc.26088.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. SIERI S , Muti P, Claudia A, Berrino F, et al
    Prospective study on the role of glucose metabolism in breast cancer occurrence.
    Int J Cancer. 2011 Mar 16. doi: 10.1002/ijc.26071.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. LUKANOVA A , Surcel HM, Lundin E, Kaasila M, et al
    Circulating estrogens and progesterone during primiparous pregnancies and risk of maternal breast cancer.
    Int J Cancer. 2011 Mar 16. doi: 10.1002/ijc.26070.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. MICHELS KB , Terry KL, Eliassen AH, Hankinson SE, et al
    Adult weight change and incidence of premenopausal breast cancer.
    Int J Cancer. 2011 Mar 16. doi: 10.1002/ijc.26069.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. MEGO M , Mani SA, Lee BN, Li C, et al
    Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy.
    Int J Cancer. 2011 Mar 8. doi: 10.1002/ijc.26037.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. SHAO R , Scully SJ Jr, Yan W, Bentley B, et al
    The novel lupus antigen related protein acheron enhances the development of human breast cancer.
    Int J Cancer. 2011 Mar 8. doi: 10.1002/ijc.26015.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. URAKAWA H , Nishida Y, Wasa J, Arai E, et al
    Inhibition of hyaluronan synthesis in breast cancer cells by 4-Methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo.
    Int J Cancer. 2011 Mar 8. doi: 10.1002/ijc.26014.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
41. LIU L , Zhang J, Wu AH, Pike MC, et al
    Invasive breast cancer incidence trends by detailed race/ethnicity and age.
    Int J Cancer. 2011 Feb 23. doi: 10.1002/ijc.26004.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. TANG SC , Lagas JS, Lankheet NA, Poller B, et al
    Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration.
    Int J Cancer. 2011 Feb 23. doi: 10.1002/ijc.26000.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. NADERI A , Liu J, Francis GD
    A feedback loop between BEX2 and ErbB2 mediated by c-Jun signaling in breast cancer.
    Int J Cancer. 2011 Feb 3. doi: 10.1002/ijc.25977.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. KLAWITTER J , Klawitter J, Gurshtein J, Corby K, et al
    Bezielle (BZL101)-induced oxidative stress damage followed by redistribution of metabolic fluxes in breast cancer cells: A combined proteomic and metabolomic study.
    Int J Cancer. 2011 Feb 3. doi: 10.1002/ijc.25965.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. TENG Y , Liu M, Cowell JK
    Functional interrelationship between the WASF3 and KISS1 metastasis-associated genes in breast cancer cells.
    Int J Cancer. 2011 Feb 3. doi: 10.1002/ijc.25964.
    PubMed     Text format     Related articles   
    
    
    
    
46. DIETRICH CG , Vehr AK, Martin IV, Gassler N, et al
    Downregulation of breast cancer resistance protein in colon adenomas reduces cellular xenobiotic resistance and leads to accumulation of a food-derived carcinogen.
    Int J Cancer. 2011 Feb 3. doi: 10.1002/ijc.25958.
    PubMed     Text format     Related articles   
    
    
    
    
47. HEYN H , Engelmann M, Schreek S, Ahrens P, et al
    MicroRNA miR-335 is crucial for the BRCA1 regulatory cascade in breast cancer development.
    Int J Cancer. 2011 Feb 3. doi: 10.1002/ijc.25962.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
48. THAIPARAMBIL JT , Bender L, Ganesh T, Kline E, et al
    Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation.
    Int J Cancer. 2011 Jan 20. doi: 10.1002/ijc.25938.
    PubMed     Text format     Related articles   
    
    
    
    
49. HSIEH TC , Wong C, Bennett DJ, Wu JM, et al
    Regulation of p53 and cell proliferation by resveratrol and its derivatives in breast cancer cells: An in silico and biochemical approach targeting integrin alphavbeta3.
    Int J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
50. STENDAHL M , Nilsson S, Wigerup C, Jirstrom K, et al
    p27(Kip1) is a predictive factor for tamoxifen treatment response but not a prognostic marker in premenopausal breast cancer patients.
    Int J Cancer. 2010;127:2851-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. WEIJERS EM , Koolwijk P, van Hinsbergh VW, van Nieuw Amerongen GP, et al
    Fibrin beta15-42 domain is cryptic in intact fibrinogen: comment on the study by A. Sahni et al.
    Int J Cancer. 2010;127:2981-2.
    PubMed     Text format     Related articles   
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: